Litcius/Paper detail

Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial

Gustavo H. Dayan, Nadine Rouphael, Stephen R. Walsh, Aiying Chen, Nicole Grunenberg, Mary Allen, Johannes Antony, Kwaku Poku Asante, Amit Suresh Bhate, Tatiana Beresnev, Matthew Bonaparte, Médéric Celle, Maria Angeles Ceregido, Lawrence Corey, D.V. Dobrianskyi, Bo Fu, Marie-Hélène Grillet, Maryam Keshtkar‐Jahromi, Michal Juraska, Jia Jin Kee, Hannah Kibuuka, Marguerite Koutsoukos, Roger Masotti, Nelson L. Michael, Kathleen M. Neuzil, Humberto Reynales, Merlin L. Robb, Sandra M. Villagómez Martínez, Fredrick Sawe, Lode Schuerman, Tina Tong, John J. Treanor, T. Anh Wartel, Carlos A. DiazGranados, Roman M. Chicz, Sanjay Gurunathan, Stephen J. Savarino, Saranya Sridhar, Karina Abalos, José Accini, Naveena Aloysia, John Amuasi, Nana Akosua Ansah, David Benkeser, Aude Berge, Hanna Beyko, Oleksandra Bilotkach, Thomas Breuer, Alberto Cadena Bonfanti, Elisabeth Bukusi, Richard Canter, Jaime Augusto Carrillo, Danaya Chansinghakul, Florence Coux, Chandan Krushna Das, Santa Kumar Das, Louis Devlin, Luis Espinoza, Michael P. Fay, Dean Follmann, Carina Frago, Agnes Garinga, Peter B. Gilbert, Claudia González, Maria Angelica Granados, Lea Guillery, Ying Huang, Kathy Hudzina, Manish Kumar Jain, Piush Kanodia, Nitin Khandelwal, Cissy Kityo Mutuluuza, Francis Kiweewa, Noah Kiwanuka, Chalit Kosolsak, Darshna Kukian, Jitendra Singh Kushwaha, Thelma Laot, Eduardo López-Medina, Hugo Macareno Arroyo, Kishorchandra Mandaliya, Stephanie Mamod, Somnath Mangarule, Javier Martínez, Scott McClelland, Lisa Menard, Sandra Mendoza, Satyajit Mohapatra, Catherine Moreau, Nelly Mugo, Videlis Nduba, Fernando Noriega, Patricia Nahirya Ntege, Brenda Okech, María Calado Otero, Samuel Gurrion Ouma, Janet Oyieko, Mercedes Paredes, Erwin Pardo, Svitlana Postol

2023The Lancet Respiratory Medicine24 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBivalent (engine)AdjuvantDouble blindPlaceboRecombinant DNASevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)VirologyInternal medicineAlternative medicineInfectious disease (medical specialty)PathologyDiseaseGeneChemistryMetalBiochemistryOrganic chemistrySARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approachesAnimal Virus Infections Studies
Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, parallel, randomised, modified double-blind, placebo-controlled trial | Litcius